Abstract
Treatment of osteoporosis remains a therapeutic challenge. The effect of Apium Nodiflorum extract on development of experimental osteoporosis, pain thresholds and carrageenan-induced inflammation has been studied in ovariectomized osteoporotic Wistar rats. After osteoporosis verification rats were randomized and received vehicle only, HPLC-standardized Apium extract (equal to 2.4 mg/kg Quercetin) or Genistein (2.5 mg/kg) for 8 weeks. To verify the effect of Apium on the development of osteoporosis, bone mineral density (BMD) and bone mineral content (BMC), bone histology and plasma levels of IL-6 and RANKL were measured 6 months after ovariectomy and 8 weeks after treatment with Apium extract or Genistein as comparator. Inflammatory hyperalgesia was induced by intraplantar injection of 1% Carrageenan. Apium extract and Genistein impeded the development of osteoporosis (significant differences were shown for BMC and BMD levels in drug vs. vehicle treated rats) and improved bone histology and histological score. Apium and Genistein decreased IL-6 level. Both treatments alleviated mechanical hyperalgesia, decreased exudative reaction and lowered inflammatory pain threshold. The results suggested that Apium extract could be an alternative therapy for post-menopausal osteoporosis.
Keywords: Apium, genistein, inflammatory hyperalgesia, osteoporosis, pain thresholds.
Current Pharmaceutical Biotechnology
Title:The Effect of Apium Nodiflorum in Experimental Osteoporosis
Volume: 16 Issue: 5
Author(s): Ana P. Tsakova, Slavina K. Surcheva, Vasya S. Bankova, Milena P. Popova, Dimitar R. Peev, Plamen R. Popivanov, Kiril L. Surchev, Mariya D. Ratkova, Lachezar K. Surchev and Mila V. Vlaskovska
Affiliation:
Keywords: Apium, genistein, inflammatory hyperalgesia, osteoporosis, pain thresholds.
Abstract: Treatment of osteoporosis remains a therapeutic challenge. The effect of Apium Nodiflorum extract on development of experimental osteoporosis, pain thresholds and carrageenan-induced inflammation has been studied in ovariectomized osteoporotic Wistar rats. After osteoporosis verification rats were randomized and received vehicle only, HPLC-standardized Apium extract (equal to 2.4 mg/kg Quercetin) or Genistein (2.5 mg/kg) for 8 weeks. To verify the effect of Apium on the development of osteoporosis, bone mineral density (BMD) and bone mineral content (BMC), bone histology and plasma levels of IL-6 and RANKL were measured 6 months after ovariectomy and 8 weeks after treatment with Apium extract or Genistein as comparator. Inflammatory hyperalgesia was induced by intraplantar injection of 1% Carrageenan. Apium extract and Genistein impeded the development of osteoporosis (significant differences were shown for BMC and BMD levels in drug vs. vehicle treated rats) and improved bone histology and histological score. Apium and Genistein decreased IL-6 level. Both treatments alleviated mechanical hyperalgesia, decreased exudative reaction and lowered inflammatory pain threshold. The results suggested that Apium extract could be an alternative therapy for post-menopausal osteoporosis.
Export Options
About this article
Cite this article as:
Tsakova P. Ana, Surcheva K. Slavina, Bankova S. Vasya, Popova P. Milena, Peev R. Dimitar, Popivanov R. Plamen, Surchev L. Kiril, Ratkova D. Mariya, Surchev K. Lachezar and Vlaskovska V. Mila, The Effect of Apium Nodiflorum in Experimental Osteoporosis, Current Pharmaceutical Biotechnology 2015; 16 (5) . https://dx.doi.org/10.2174/1389201015666141229104102
DOI https://dx.doi.org/10.2174/1389201015666141229104102 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Traumatic Brain Injury: Central and Peripheral Role of α7 Nicotinic Acetylcholine Receptors
Current Drug Targets Mechanisms of the Penetration of Blood-Borne Substances into the Brain
Current Neuropharmacology Approaches to Target Profiling of Natural Products
Current Medicinal Chemistry Patent Selections
Recent Patents on Anti-Cancer Drug Discovery Patent Selections:
Recent Patents on Chemical Engineering Antioxidant Agents in Alzheimers Disease
Central Nervous System Agents in Medicinal Chemistry Editorial [Hot Topic: New Avenues of Research on Multiple Sclerosis from the Perspective of Chronic Cerebrospinal Venous Insufficiency Paradigm (Guest Editor: Marian Simka)]
Reviews on Recent Clinical Trials Metabolism of the Antituberculosis Drug Ethionamide
Current Drug Metabolism <i>In Silico</i> and <i>In Vitro</i> Study: COX-2 Inhibition by Ethanol Extract of Dayak Onion Bulb (<i>Eleutherine Americana</i> Merr) as Treatment Innovation of Benign Prostatic Hyperplasia (BPH)
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Identification of Plant Protein Kinases in Response to Abiotic and Biotic Stresses Using SuperSAGE
Current Protein & Peptide Science PDE3 Inhibition by Cilostazol Ameliorated Behavioral and Biochemical Deficits in Prenatal Alcohol Induced Experimental ADHD
Current Enzyme Inhibition Pharmacology of the Human Saphenous Vein
Current Vascular Pharmacology Regulation and Function of Rankl in Arterial Calcification
Current Pharmaceutical Design MIF and the Genetic Basis of Macrophage Responsiveness
Current Immunology Reviews (Discontinued) Natural Products in Mitigation of SARS CoV Infections
Current Medicinal Chemistry Synthetic Curcumin Analog UBS109 Inhibits the Growth of Head and Neck Squamous Cell Carcinoma Xenografts
Current Cancer Drug Targets Recent Developments in Antiplatelet Therapy after Percutaneus Coronary Intervention
Cardiovascular & Hematological Disorders-Drug Targets An Update on Potential Molecular Mechanisms Underlying the Actions of Snake Venom L-amino Acid Oxidases (LAAOs)
Current Medicinal Chemistry A Comparison of Adverse Drug Reactions Between High- and Standard- Dose Trimethoprim-Sulfamethoxazole in the Ambulatory Setting
Current Drug Safety Pharmacogenetics of the Antiplatelet Effect of Aspirin
Current Pharmaceutical Design